Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 13.33% is 41% below its 5-year average of 22.56%, near the low end of its 5-year range (13.03%–29.94%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.78% below its 12-month average of 16.61%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.33%.
DEBT TO ASSETS RATIO
13.33%
DEBT TO ASSETS RATIO AVG TTM
16.61%
DEBT TO ASSETS RATIO AVG 3Y
22.95%
DEBT TO ASSETS RATIO AVG 5Y
22.56%
DEBT TO ASSETS RATIO AVG 10Y
17.77%
DEBT TO ASSETS RATIO AVG 15Y
12.28%
DEBT TO ASSETS RATIO AVG 20Y
13.76%
CURRENT VS TTM AVG
-19.78%
CURRENT VS 3Y AVG
-41.92%
CURRENT VS 5Y AVG
-40.91%
CURRENT VS 10Y AVG
-25.01%
CURRENT VS 15Y AVG
+8.51%
CURRENT VS 20Y AVG
-3.15%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 665 covered companies
CURRENT VS SECTOR MEDIAN
+13227.06%
vs the sector median at left
LivaNova PLC
Market Cap
$4.13B
Debt to Assets Ratio
13.33%
TTM Avg
16.61%
3Y Avg
22.95%
5Y Avg
22.56%
Market Cap
$4.07B
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.36B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.37B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.43B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.45B
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.65B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LivaNova PLC (LIVN) | $4.13B | 13.33% | 16.61% | 22.95% | 22.56% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.07B | 0.10% | N/A | N/A | N/A |
| ICU Medical, Inc. (ICUI)vs › | $3.96B | 0.32% | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.36B | 0.01% | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | 0.08% | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | 0.41% | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | 0.64% | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 0.38% | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.65B | 0.20% | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.66B | 0.09% | N/A | N/A | N/A |
Debt/Assets
13.3%
Debt/Equity
0.27
Current Ratio
1.45
Interest Coverage
4.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 13.33% |
| 2026-03-31 | 13.29% |
| 2025-12-31 | 18.16% |
| 2025-09-30 | 19.02% |
| 2025-06-30 | 19.26% |
| 2025-03-31 | 26.49% |
| 2024-12-31 | 27.00% |
| 2024-09-30 | 26.95% |
| 2024-06-30 | 27.62% |
| 2024-03-31 | 27.51% |
| 2023-12-31 | 26.36% |
| 2023-09-30 | 26.66% |
| 2023-06-30 | 26.65% |
| 2023-03-31 | 25.33% |
| 2022-12-31 | 25.29% |
| 2022-09-30 | 26.11% |
| 2022-06-30 | 21.75% |
| 2022-03-31 | 20.79% |
| 2021-12-31 | 13.03% |
| 2021-09-30 | 13.11% |
| 2021-06-30 | 29.94% |
| 2021-03-31 | 30.05% |
| 2020-12-31 | 29.55% |
| 2020-09-30 | 28.00% |
| 2020-06-30 | 27.98% |
| 2020-03-31 | 24.19% |
| 2019-12-31 | 16.37% |
| 2019-09-30 | 15.82% |
| 2019-06-30 | 10.31% |
| 2019-03-31 | 9.21% |
| 2018-12-31 | 6.60% |
| 2018-09-30 | 6.02% |
| 2018-06-30 | 6.20% |
| 2018-03-31 | 6.78% |
| 2017-12-31 | 5.83% |
| 2017-09-30 | 4.77% |
| 2017-06-30 | 4.96% |
| 2017-03-31 | 5.19% |
| 2016-12-31 | 5.25% |
| 2016-09-30 | 5.87% |
| 2016-06-30 | 6.03% |
| 2016-03-31 | 6.59% |
| 2015-12-31 | 6.91% |
| 2015-10-18 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-04-30 | 0.00% |
| 2015-01-31 | 0.00% |
| 2014-10-31 | 0.00% |
| 2014-07-31 | 0.00% |
| 2014-04-30 | 0.00% |
| 2014-01-31 | 0.00% |
| 2013-10-31 | 0.00% |
| 2013-07-31 | 0.00% |
| 2013-04-30 | 0.00% |
| 2013-01-31 | 0.00% |
| 2012-10-31 | 0.00% |
| 2012-07-31 | 0.00% |
| 2012-04-30 | 0.00% |
| 2012-01-31 | 0.00% |
| 2011-10-31 | 3.57% |
| 2011-07-31 | 3.53% |
| 2011-04-30 | 3.33% |
| 2011-01-31 | 3.40% |
| 2010-10-31 | 3.67% |
| 2010-07-31 | 4.66% |
| 2010-04-30 | 9.93% |
| 2010-01-31 | 15.36% |
| 2009-10-31 | 25.94% |
| 2009-07-31 | 44.23% |
| 2009-04-30 | 55.64% |
| 2009-01-31 | 61.64% |
| 2008-10-31 | 75.26% |
| 2008-07-31 | 86.97% |
| 2008-04-30 | 91.76% |
| 2008-01-31 | 91.76% |
| 2007-10-31 | 100.52% |
| 2007-07-31 | 98.31% |
| 2007-04-30 | 96.26% |
| 2007-01-31 | 95.31% |
| 2006-10-31 | 88.30% |
| 2006-07-31 | 85.04% |
| 2006-04-30 | 83.72% |
| 2006-01-31 | 79.62% |
| 2005-10-31 | 73.11% |
| 2005-07-31 | 3.55% |
| 2005-04-30 | 3.03% |
| 2005-01-31 | 3.37% |
| 2004-10-31 | 3.49% |
| 2004-07-31 | 10.30% |
| 2004-04-30 | 10.79% |
| 2004-01-31 | 10.82% |
| 2003-10-31 | 12.47% |
| 2003-07-31 | 14.00% |
| 2003-04-30 | 11.53% |
| 2003-01-31 | 10.45% |
| 2002-10-31 | 10.96% |
